Antidiabetic and antihyperlipidemic effect of Alstonia scholaris linn bark in streptozotocin induced diabetic rats

Indian Journal of Pharmaceutical Education and Research

Volumn 45, Issue 2, 2011, Pages 114-120

  Bandawane, Deepti ^a   Juvekar, Archana ^b   Juvekar, Manasi ^c  

^a Progressive Education Society s Modern College of Pharmacy   (India)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^c GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Alstonia scholaris; Antiatherogenic; Antidiabetic; Antihyperlipidemic; Streptozotocin

Indexed keywords

ALSTONIA SCHOLARIS EXTRACT; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; GLYCOGEN; HEMOGLOBIN; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARK; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HEMOGLOBIN BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79958705971     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gale EAM, Anderson JU. Diabetes mellitus and other disorders of metabolism. In: Kumar P, Clark M, editors. Clinical Medicine. 5th ed. London: WB Saunders; 2002. 1069-101.
2. Mohanty P, Hamouda W, Garg R, Aljada A, Grahim H, Dandona P. Glucose challenge stimulates reactive oxygen species generation by leucocytes. J. Clin. Endocrinol. Metab. 2000; 85: 2970-2973.
3. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025 prevalence, numerical estimates and projections. Diabetes Care 1998; 21:1414-1431.
4. Rang HP, Dale MM, Ritter JM, Flower RJ. Rang and Dale's Pharmacology. 6th ed. Philadelphia: Churchill Livingston Elsevier; 2007.
5. Kirtikar KR, Basu BD. Indian Medicinal Plants. Vol.- 2. Dehradun: International Book Distributors; 1999.
6. Nadkarni AK, Indian Materia Medica, Vol.-1. Mumbai: Bombay Popular Prakashan; 1976.
7. Lin SC, Lin CC, Linn YH, Supriyatna S, Pal SL. The protective effect of Alstonia scholaris R.Br. on hepatotoxin induced acute lever damage. Am. J. Clin. Med. 1996; 24: 153-164.
8. Saraswathi V, Ramamoorthy N, Subramaniam S, Mathuram V, Gunaseharam P, Govindasamy S. Inhibition of glycolysis and respiration of sarcoma 180 cells by echitamine chloride. Chemotherapy 1998; 44: 198-205.
9. Shah VK, Chauhan MD. Abhinav Madhumeh Vigyana, 1st ed. Varanasi: Chaukhamba Orientalia; 2003.
10. Turner RA. Screening Methods in Pharmacology, 1st ed. New York: Academic Press; 1971.
11. Arambewela LSR, Arawwawala LDAM, Ratnasooriya WD. An antidiabetic activity of aqueous and ethanolic extracts of Piper betle leaves in rats. J. Ethnopharmacol. 2005; 102: 239-245.
12. Adaramoye OA, Adeyemi EO. Hypoglycemic and hypolipidemic effects of fractions from kolaviron, a biflavonoid complex from Garcinia kola streptozotocin induced diabetes mellitus rats. J. Pharma. Pharmacol. 2006; 58:121-128.
13. Friedewald WT, Levy RI, Fradrickson DS. Estimation of concentration of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clinical Chemistry 1972; 18: 499-502.
14. Carrol VV, Longly RW, Joseph HR. Determination of glycogen in liver and muscle by use of anthrone reagent. J. Biol. Chem. 1956; 220: 583-593.
15. Tiwari AK, Madhusudana RJ. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospectus. Current Science 2002; 83: 30-38.
16. Tripathi KD. Essentials of Medical Pharmacology, 5th ed. New Delhi: Jaypee Publication; 2003.
17. Erememisoglu A, Kelestimur F, Kokel AH, Utsun H, Tekol Y, Ustdal M. Hypoglycemic effect of Zizyphus jujube leaves. J. Pharm. Pharmacol. 1995; 47: 72-74.
18. Grover JK, Vats U, Yadav S. Effect of feeding aqueous extract of Petrocarpus merscupium on glycogen content of the tissues and the key enzymes of carbohydrate metabolism. Molecular Cellular Biochemistry 2002; 241: 53-59.
19. Kawalali G, Tuncel H, Goksel S, Hatemi HH. Hypoglycemic activity of Urtica pilulifera in streptozotocin diabetic rats. J. Ethnopharmacol. 2002; 84: 241-245.
20. Guyton A.C., Hall J.E. Textbook of Medical Physiology, 9th ed. Philadelphia; WB Saunders; 1996.
21. Monnier VK. Non enzymatic glycosylation and browning in diabetes and aging. Diabetes 1982; 31: 57-66.
22. Chang AT, Nobel J. Estimation of HbA1c like glycosylated proteins in kidneys of streptozotocin diabetes and controlled rats. Diabetes 1979; 28: 408-415.
23. Tattersalt R. Targets of therapy for NIDDM. Diabetes Res. Clin. Pract. 28 (Suppl.), 1995: 49-55.
24. Davis SN, Granner DK. Insulin, Oral Hypoglycemic Agents and the Pharmacology of the Endocrine Pancreas. In: Hardman JG., Limberd LE, editors. Goodman and Gillman's The Pharmacological Basis of Therapeutics, 10th ed. USA: McGrew Hill; 2001: 1679-1714.
25. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty acid cycle, its role in insulin sensitivity and metadisturbances in diabetes mellitus. Lancet 1963; 1: 785-789.
26. Sivajyothi V, Dey A, Jaykar B, Rajkapoor B. Antihyperglycemic, antihyperlipidemic and antioxidant effect of Phyllanthus rheedii on streptozotocin induced diabetic rats. Iranian Journal of Pharmaceutical Research 2008; 7(1): 53-59.